Showing results (31-40 of 123) with videos related to
Sort By:
Pageof 13
Rheumatology International|December 26, 2006
Is the CD14 C159T polymorphism effective in the development of secondary amyloidosis in Familial Mediterranean fever?Ozlem Keskin, Engin Yilmaz, Sim Kutlay, et al.International Urology and Nephrology|April 10, 2004
Radiocontrast-induced nephrotoxicity and urinary alpha-glutathione S-transferase levels: effect of amlodipine administrationMustafa Arici, Celalettin Usalan, Bülent Altun, et al.Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|October 4, 2005
U-shaped association of body mass index with inflammation and atherosclerosis in hemodialysis patientsSerkan Kahraman, Rahmi Yilmaz, Devrim Akinci, et al.Blood Purification|August 28, 2012
Supplementary ultrafiltration may improve inflammation and cardiac dysfunction in patients with high interdialytic weight gainRahmi Yilmaz, Mustafa Arici, Tolga Yildirim, et al.Iranian Journal of Kidney Diseases|May 4, 2020
The Weekend Effect in Chronic Hemodialysis Patients, a Single Center ExperienceTolga Yildirim, Yusuf Ziya Sener, Ertugrul Cagri Bolek, et al.Hemodialysis International. International Symposium on Home Hemodialysis|October 10, 2007
A rare complication of hemodialysis catheters: superior vena cava syndromeHadim Akoglu, Rahmi Yilmaz, Bora Peynircioglu, et al.Nephron. Clinical Practice|April 13, 2005
Efficacy and safety of intravenous iron therapy for HCV-positive haemodialysis patientsSerkan Kahraman, Rahmi Yilmaz, Gultekin Genctoy, et al.Nephron|October 3, 2023
Chronic Kidney Disease Risk in Living Kidney Transplant Donors: A Long-Term Follow-Up StudyGuldehan Haberal, Tolga Yildirim, Seref Rahmi Yilmaz, et al.Artificial Organs|November 25, 2005
The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: conventional, Doppler, and tissue Doppler echocardiographic parametersAlper Kirkpantur, Serkan Kahraman, Rahmý Yilmaz, et al.Renal Failure|September 7, 2012
Major barriers against renin-angiotensin-aldosterone system blocker use in chronic kidney disease stages 3-5 in clinical practice: a safety concern?Tolga Yildirim, Mustafa Arici, Serhan Piskinpasa, et al.Pageof 13